CXCL12 and lung carcinoma: CXCR4 receptor binds its ligand, CXCL12 (SDF-1), which is overexpressed in lung cancer cells, and the interaction of this receptor-ligand drives tumor proliferation, migration, and therapy resistance (Cojoc et al., 2013).